Skip to search formSkip to main contentSkip to account menu

TMC 278

Known as: 278, TMC, TMC-278, TMC278 
National Institutes of Health

Related topics

Related topics

2 relations
R278474

Broader (1)

Rilpivirine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption
ABSTRACT Rilpivirine (TMC278) is a highly potent nonnucleoside reverse transcriptase inhibitor (NNRTI) representing an effective… 
2015
2015
Functionalized chitosan derivatives as nonviral vectors: physicochemical properties of acylated N,N,N-trimethyl chitosan/oligonucleotide nanopolyplexes.
Cationic polymers have recently attracted attention due to their proven potential for nonviral gene delivery. In this study, we… 
2012
2012
Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance Database.
2012
2012
Effects of degree of quaternization on the preparation and characterization of insulin-loaded trimethyl chitosan polyelectrolyte complexes optimized by central composite design
The aim of the present study was to investigate the effects of varying degrees of quaternization (DQ: 22, 35 and 41%) on the… 
2011
2011
Monographs: Rilpivirine: a new addition to the anti-HIV-1 armamentarium.
2011
2011
Pooled Week 96 efficacy, resistance and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV, TMC278) versus efavirenz (EFV) in treatment-naïve, HIV-1…
Lost to follow-up, non-compliance, withdrew consent, ineligible to continue, sponsor's decision • Similar response rates for RPV… 
2011
2011
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1–Infected Patients
2010
2010
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK 
Review
2009
Review
2009
HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
The recent availability of new antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection has… 
1996
1996
Pharmacokinetic Analysis and Antiepileptic Activity of Tetra-Methylcyclopropane Analogues of Valpromide
AbstractPurpose. The described structure pharmacokinetic pharmacodynamic relationships (SPPR) study explored the utilization of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)